Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020.

Susanne B NicholasKenn B DarathaRadica Z AlicicCami R JonesLindsey M KornowskeJoshua J NeumillerSamuel T FatobaSheldon X KongRakesh SinghKeith C NorrisKatherine R Tuttle

Published in: Diabetes, obesity & metabolism (2023)

Prescribing for GDMT was suboptimal and waned quickly in patients with diabetes and CKD. Type of primary health insurance coverage and health system were associated with GDMT prescribing.

Keyphrases

chronic kidney disease
health insurance
affordable care act
end stage renal disease
primary care
healthcare
adverse drug
electronic health record